Dear Min,

regarding #1 some things come to my mind:

- What is the Kd that you got from the Biacore? And did you make sure that
the sample is concentrated enough (both on gel filtration and in
crystallization) to have a "sufficient"  amount  in the complex.

- did you use the same buffer systems? Your Kd might be different in
different buffers.

Best

Alex

 

 

 

 

 

Dr. Alexander Pautsch 
Boehringer Ingelheim Pharma GmbH & Co. KG
Dept. Lead Identific. and Optim. Sup. Ge
Tel.: +49 (7351) 54-4683
Fax: +49 (7351) 54-97924 
mailto:alexander.paut...@boehringer-ingelheim.com
<mailto:alexander.paut...@boehringer-ingelheim.com> 

Boehringer Ingelheim Pharma GmbH & Co. KG, Sitz: Ingelheim am Rhein;
Registergericht Mainz: HR A 22206; Komplementär Boehringer Ingelheim
Deutschland GmbH; Geschäftsführung: Dr. Engelbert Günster (Vorsitzender),
Ralf Gorniak, Mark Hagmann, Michael Klein, Dr. Martin Wanning; Vorsitzender
des Aufsichtsrates: Prof. Dr. Dr. Andreas Barner; Sitz: Ingelheim am Rhein;
Registergericht Mainz: HR B 23260

Diese E-Mail ist vertraulich zu behandeln. Sie kann besonderem rechtlichen
Schutz unterliegen. Wenn Sie nicht der richtige Adressat sind, senden Sie
bitte diese E-Mail an den Absender zurück, löschen die eingegangene E-Mail
und geben den Inhalt der E-Mail nicht weiter. Jegliche unbefugte Bearbeitung,
Nutzung, Vervielfältigung oder Verbreitung ist verboten. / This e-mail is
confidential and may also be legally privileged. If you are not the intended
recipient please reply to sender, delete the e-mail and do not disclose its
contents to any person. Any unauthorized review, use, disclosure, copying or
distribution is strictly prohibited.

Von: CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] Im Auftrag von m
zhang
Gesendet: Freitag, 16. September 2011 04:20
An: CCP4BB@JISCMAIL.AC.UK
Betreff: [ccp4bb] crystallization of complex and ...

 

Dear all,

 

I have two questions:

 

First, I was trying to crystallize a complex of two proteins. Both proteins
has been crystallized before. The two proteins bind to each other based on
Biacore study, but they didn't form a single peak on gel filtration. When I
mixed them at 1:1 ratio, the crystals I got contain only one of the two
proteins. I was suggested to increase the ratio, for example 1.5:1, to
increase the probability of co-crystallization which I will try. But I do
want to hear if there are other possible ways to try. What would you try if
you were in my situation? 

 

Second is about reusing of Ni-NTA resin. According to Qiagen's instruction,
after using fresh Ni-NTA resin, one only needs to wash the used Ni resin
first with 0.5M NaOH, then with your own buffer. After that the resin is
ready to be reused until it needs being recharged. But my question is: Once
immidazole competes with His-tagged protein and binds to Ni-resin, how can
immidazole be rinsed off with the same buffer(usually pH is above 7) one uses
to purify the protein?

 

Thank you for any suggestion or comment.

 

Min

Reply via email to